Skip to main content
Premium Trial:

Request an Annual Quote

Blueprint Initiative Spins Out New Company; Inaugural Product to Launch in May

NEW YORK, April 21 (GenomeWeb News) - Mount Sinai Hospital's Blueprint Initiative has spun out a new company that will soon release its first informatics product, the hospital said earlier this week.


The company, Unleashed Informatics, was created in part with a CA$1.2 million ($970,000) grant from Sun Microsystems of Canada. Together with Blueprint it will unveil its inaugural hardware and software platform at the Bio-IT World Conference in Bostonnext month.


"At the same time, Blueprint's commitment to developing leading-edge, open-source standards-based, and freely available public databases like BIND remains as strong as ever," Christopher Hogue, Blueprint's principal investigator and acting CEO of Unleashed Informatics, said in a statement.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.